Rivastigmin and impaired motor function.
In this case study, we describe the case of an 88-year-old female patient diagnosed with Alzheimer's disease who developed a severe motor dysfunction as a side effect of rivastigmin treatment. There have been reports on motor dysfunctions caused by other choline esterase inhibitors.
Heinze
M
M
Department of Psychiatry and Psychotherapy, Landesklinik Teupitz, Teupitz, Germany. heinzem@zedat.fu-berlin.de
Andreae
D
D
Grohmann
R
R
D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000150:complications* / Q000188:drug therapy / Q000523:psychology; D002219:Carbamates / Q000009:adverse effects* / Q000627:therapeutic use; D002389:Catatonia / Q000139:chemically induced; D004409:Dyskinesia, Drug-Induced / Q000503:physiopathology*; D005260:Female; D006801:Humans; D018696:Neuroprotective Agents / Q000009:adverse effects* / Q000627:therapeutic use; D048448:Phenylcarbamates; D000068836:Rivastigmine
D002219:Carbamates; D018696:Neuroprotective Agents; D048448:Phenylcarbamates; D000068836:Rivastigmine